SCOPUS 정보 검색 플랫폼

Volumn 21, Issue 5, 2001, Pages 493-498

Retreatment effect of NPe6 photodynamic therapy on the normal primate macula

(8) Nakashizuka, Takayuki a Mori, Keisuke b Hayashi, Naoki b Anzail, Kaname b Kanail, Kaname b Yoneya, Shin b Moshfeghi, Darius M c,d Peyman, Gholam A c,d

a SAITAMA MEDICAL UNIVERSITY (Japan)

b TORANOMON HOSPITAL (Japan)

c TULANE UNIVERSITY HEALTH SCIENCES CENTER (United States)

d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER (United States)

Author keywords

Age related macular degeneration; Mono L aspartyl chlorin e6; Photodynamic therapy; Primate model; Repeated treatment

Indexed keywords

CHLORINE DERIVATIVE; MONO LEVO ASPARTYL CHLORIN E6; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; DIODE LASER; DOSE RESPONSE; ENUCLEATION; EYE FUNDUS; HISTOPATHOLOGY; MACACA; MICROSCOPY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTORECEPTOR; PIGMENT EPITHELIUM; RETINA BLOOD VESSEL; RETINA FOVEA; RETINA MACULA LUTEA; RETREATMENT;

EID: 0034792643 PISSN: 0275004X EISSN: None Source Type: Journal
DOI: 10.1097/00006982-200110000-00012 Document Type: Article

Times cited : (12)

References (10)

1
- 0032819606
- Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study
- (1999) Arch Ophthalmol , vol.117 , pp. 1161-1173
- Miller, J.W.¹ Schmidt-Erfurth, U.² Sickenberg, M.³

2
- 0032871253
- Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study
- (1999) Arch Ophthalmol , vol.117 , pp. 1177-1187
- Schmidt-Erfurth, U.¹ Miller, J.W.² Sickenberg, M.³

3
- 0342632445
- Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin one-year results of 2 randomized clinical trials - TAP report 1
- (1999) Arch Ophthalmol , vol.117 , pp. 1329-1345

4
- 4243262136
- Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration using verteporfin (Visudyne): Two-year results of 2 randomized clinical trials - TAP report 5
- Abstract
- (2000) Invest Ophthalmol Vis Sci , vol.41 , Issue.SUPPL.
- Bressler, S.B.¹

5
- 0034074574
- Problems with and pitfalls of photodynamic therapy
- (2000) Ophthalmology , vol.107 , pp. 29-35
- Peyman, G.A.¹ Kazi, A.A.² Unal, M.³

6
- 0033868186
- Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels
- (2000) Ophthalmic Surg Lasers , vol.31 , pp. 323-327
- Peyman, G.A.¹ Kazi, A.A.² Moshfeghi, D.³

7
- 0033208744
- Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey
- (1999) Ophthalmology , vol.106 , pp. 1915-1923
- Reinke, M.H.¹ Canakis, C.² Husain, D.³

8
- 0033504871
- Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-apartyl chlorin e6)
- (1999) Ophthalmology , vol.106 , pp. 1384-1391
- Mori, K.¹ Yoneya, S.² Ohta, M.³

9
- 0032693213
- Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys
- (1999) Ophthalmic Surg Lasers , vol.30 , pp. 750-753
- Moshfeghi, D.M.¹ Peyman, G.A.² Kazi, A.A.³

10
- 0034019209
- Threshold power levels for NPe6 photodynamic therapy
- (2000) Ophthalmic Surg Lasers , vol.31 , pp. 136-142
- Kazi, A.A.¹ Peyman, G.A.² Unal, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.